4.8 Article

Case Report: Coexistence of Multiple Myeloma and Auricular Chondritis in VEXAS Syndrome

Related references

Note: Only part of the references are listed.
Article Dermatology

Further characterization of clinical and laboratory features in VEXAS syndrome: large-scale analysis of a multicentre case series of 116 French patients

S. Georgin-Lavialle et al.

Summary: VEXAS syndrome is a newly described autoinflammatory syndrome associated with somatic mutations of UBA1. It presents a wide range of clinical features, with different prognostic profiles identified, and the UBA1 p.Met41Leu mutation is associated with a better prognosis.

BRITISH JOURNAL OF DERMATOLOGY (2022)

Letter Hematology

Novel somatic mutations in UBA1 as a cause of VEXAS syndrome

James A. Poulter et al.

BLOOD (2021)

Article Hematology

Toward a pathophysiology inspired treatment of VEXAS syndrome

Mael Heiblig et al.

Summary: Therapeutic interventions for VEXAS syndrome are still in need of further exploration, with options including transplantation, drug therapies, and targeting the inflammatory cascade. Supportive care is essential in managing complications during treatment, and designing clinical trials for VEXAS patients presents challenges.

SEMINARS IN HEMATOLOGY (2021)

Article Rheumatology

Pathogenic UBA1 variants associated with VEXAS syndrome in Japanese patients with relapsing polychondritis

Naomi Tsuchida et al.

Summary: This study investigated the clinical and genetic features of 14 patients with RP, revealing a high prevalence of UBA1 variants in male patients and their association with skin lesions. Additionally, the first somatic UBA1 variant in a female patient was reported here.

ANNALS OF THE RHEUMATIC DISEASES (2021)

Article Hematology

VEXAS syndrome

Peter C. Grayson et al.

Summary: VEXAS syndrome is a monogenic disease of adulthood caused by somatic mutations in UBA1, resulting in inflammatory and hematologic symptoms. Novel UBA1 genetic variants and treatment options were discussed in the recent issue of Blood, shedding light on disease pathophysiology. VEXAS syndrome serves as a prototype for a new class of diseases.

BLOOD (2021)

Review Medicine, General & Internal

Somatic Mutations in Benign Disease

Satu Mustjoki et al.

Summary: DNA mutations occur in nearly every tissue throughout human life. If a mutated clone gains competitive advantage, clonal dominance may emerge, leading to functional consequences and disease.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Article Hematology

Benign and malignant hematologic manifestations in patients with VEXAS syndrome due to somatic mutations in UBA1

Ifeyinwa Emmanuela Obiorah et al.

Summary: Patients with VEXAS syndrome exhibit severe autoinflammatory and rheumatologic manifestations, with most also having bone marrow abnormalities such as myelodysplastic syndrome and multiple myeloma. Unique features include prominent cytoplasmic vacuoles in bone marrow and higher prevalence of thrombocytopenia and neutropenia in patients progressing to MDS.

BLOOD ADVANCES (2021)

Article Medicine, General & Internal

Somatic Mutations in UBA1 and Severe Adult-Onset Autoinflammatory Disease

David B. Beck et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Review Medicine, General & Internal

Relapsing polychondritis in Singapore: a case series and review of literature

Tyng Yu Chuah et al.

SINGAPORE MEDICAL JOURNAL (2017)

Article Medical Laboratory Technology

Consensus Guidelines for Myeloma Minimal Residual Disease Sample Staining and Data Acquisition

Maryalice Stetler-Stevenson et al.

CYTOMETRY PART B-CLINICAL CYTOMETRY (2016)

Article Rheumatology

Relapsing polychondritis associated with a lymphoplasmocytic lymphoma and erythema nodosum

Isabel Castrejon et al.

REUMATOLOGIA CLINICA (2007)

Article Clinical Neurology

Meningeal plasma cell granuloma with relapsing polychondritis - Case report

K Sato et al.

JOURNAL OF NEUROSURGERY (2006)